Postinfarction intramyocardial dissection, an interesting case report and systematic review.
Shokoufeh HajsadeghiAbdollah AmirfarhangiMarziyeh PakbazMahboubeh PazokiKiarash TanhaPublished in: Echocardiography (Mount Kisco, N.Y.) (2019)
Intramyocardial dissection (IMD) with ventricular septal rupture (VSR) following myocardial infarction (MI) is a rare subacute form of cardiac rupture. The evidence available in this regard is scarce. We aimed to share our experience and conduct a systematic review of previous cases. We searched the literature and performed a systematic review of previous cases. A total of 37 cases of IMD with VSR were included (1 our original and 36 literature cases). Mean age was 68 ± 8 years and 20 (54.1%) patients were male. Anterior and inferior MI were observed in 14 (37.8%) and 23 (62.2%) cases, respectively. The dissected area was the septum, RV, both septum and RV, or LV apex in 21 (56.8%), 9 (24.3%), 5 (13.5%), and 2 (5.4%), respectively. Apicoseptal and inferoseptal VSR were observed in 15 (40.5%) and 22 (59.5%) cases, respectively. At least one occluded artery was observed in 29 (90.6%) of cases. Reperfusion therapy was done for 15 (40.5%) cases before the VSR occurred. Surgery, percutaneous, and medical therapy were done for 26 (70.3%), 3 (8.1%), and 7 (18.9%) cases, respectively. The mortality rate was significantly higher in the medical versus surgical-treated group (85.7% versus 42.3%, P = .027). There was a trend to higher mortality in the group with dissection of both septum and RV (P = .15). We concluded that echocardiography has a critical role in diagnosing this complication. Surgery is mandatory in IMD with VSR.
Keyphrases
- systematic review
- mycobacterium tuberculosis
- left ventricular
- minimally invasive
- heart failure
- healthcare
- end stage renal disease
- randomized controlled trial
- chronic kidney disease
- cardiovascular disease
- type diabetes
- acute myocardial infarction
- brain injury
- meta analyses
- coronary artery bypass
- acute coronary syndrome
- prognostic factors
- mesenchymal stem cells
- blood brain barrier
- replacement therapy